Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ALENDRONATE SODIUM
- Alendronate for Osteonecrosis in Adults With Sickle Cell Disease
- Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease
- Efficacy and Safety of JMT103 in the Treatment of Glucocorticoid Induced Osteoporosis
- A Multi Center, Randomized, Open-label, Parallel, Phase IV Clinical Trial to Evaluate Efficacy and Safety of MASI BONE S (Alendronate Sodium Trihydrate) in Postmenopausal Women With Osteoporosis
- A Study of Alendronate Sodium Vitamin D3 Tablets on Knee Osteoarthritis
- Clinical Study Evaluating Beta Blockers Use and Fracture Risk in Patients With Primary Osteoporosis
- Efficacy of Antiresorptive and Bone Forming Material on Dental Implants
- Effect of Alendronate With β - TCP Bone Substitute in Surgical Therapy of Periodontal Intra-osseous Defects.
- Sodium Alendronate in Non Surgical Periodontal Therapy
- 99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis
- Study Investigating the Effect of Drugs Used to Treat Osteoporosis on the Progression of Calcific Aortic Stenosis.
- RA Denosumab on Bone Microstructure Study
- Twenty-Four Month Extension Study of BA058-05-003 (Abaloparatide) in Participants With Osteoporosis
- Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Alendronate (MK-0822-050)
- Study of MK-217A/Alendronate Sodium 70-mg/Vitamin D3 5600 IU Combination Tablet (MK-0217A-329)
- A Study to Evaluate Alendronate Sodium /Vitamin D3 Combination Tablets(FOSAMAX PLUS) Versus Calcitriol in the Treatment of Osteoporosis in Postmenopausal Women in China (MK-0217A-264)
- Bioequivalence Study of Alendronate Sodium Tablets 70 mg of Dr. Reddy's Under Fasting Conditions
- Fasting Study of Alendronate Sodium Tablets (70 mg) and Fosamax Tablets (70 mg)
- MK-5442 in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With an Oral Bisphosphonate (MK-5442-012)
- Fasting Study of Alendronate Sodium Tablets (10 mg) and Fosamax Tablets (10 mg)
- Alendronate in Juvenile Osteoporosis
- Alendronate Sodium 70 mg Tablet Versus Fosamax® Under Fasting Conditions.
- A Study to Test the Effect of MK0217A on Vitamin D Inadequacy in Postmenopausal Women With Osteoporosis (0217A-262)
- Alendronate Prevents Microarchitectural Deterioration of Trabecular Bone in Early Postmenopausal Women
- A Research Study to Evaluate the Safety and Effectiveness of MK0217 to Prevent and Treat Bone Loss (0217-193)(COMPLETED)
- A Study to Compare the Efficacy of Alendronate With and Without Calcium or Calcium Alone In the Treatment of Osteoporosis in Postmenopausal Women (0217-088)(COMPLETED)
- Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial
- A Randomized, Double-Blind Study to Compare the Efficacy of Treatment With Denosumab Versus Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density.
- A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density
- Network Osteoporosis Study
- Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm Assessment
- A Study to Evaluate the Safety and Tolerability of MK0217 in Women (0217-219)
- Comparison of Teriparatide With Alendronate for Treating Glucocorticoid-Induced Osteoporosis
- Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer
- Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis
- Parathyroid Hormone (PTH) With Alendronate for Osteoporosis
- Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related Osteoporosis
- Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients With Gaucher's Disease
- Osteoporosis Prevention After Heart Transplant
Clinical trials list
click for details